NeoGenomics Enters into National Agreement with Premier, Inc. to Offer Cancer Genetics Testing Services to 3,600 Hospitals

By: via Benzinga
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has entered into ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.